Human Microbiome Therapeutics Market By Product Type, By Application, and Geography  

Human Microbiome Therapeutics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Prebiotics, Probiotics, Symbiotics, Xenobiotics), By Application (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Skin Care and Oral Care, Others), and Region  

Human Microbiome Therapeutics Market size was valued at US$ 456.2 million in 2022 and is poised to grow at a significant CAGR of 22.3% from 2023-29. The microbiome is the collective genomes of the microbes consisting of bacteria, bacteriophage, fungi, protozoa, and viruses that live inside the human body. The human microbiota is made of around 10-100 trillion symbiotic microbial cells harbored by each person, primarily in the human gut. The presence of a healthy microbiome is necessary to perform specific sets of biomolecular functions in each biochemical environment across the body, especially in stomach flora and intestinal flora. Gut microbes respond quickly to a change in diet, which means the composition of the microbiome can be changed by changing eating habits.

The increasing applications of microbiome-based products in human health and technological advancements in the microbiome industry are driving the global human microbiome market growth. Also, the increasing number of digestive disorders is fueling the growth of the overall human microbiome market. For example, according to WHO, digestive disorders accounted for 375,170 deaths, 215,168 deaths in men, and 160,002 deaths in women, a crude rate of 37.2 deaths per 100,000 population (43.3 deaths/100,000 in men and 31.3 deaths/100,000 in women) worldwide in 2019. Hence, the increasing focus on human microbiome therapeutics development is the major driver in the global market. Moreover, the launches of new products in this market and collaboration between public-private organizations are influencing the global human microbiome market trend due to various high growth opportunities. The global key players are continuously driving market growth through mergers, acquisitions, and innovations.

However, stringent government regulations in the industry and the lack of awareness about human microbiome products may hamper the global human microbiome market growth. Geographically, North America held the major market share in the global human microbiome market and is expected to dominate the global market in the forecasted years.

Human Microbiome Therapeutics Market Key Developments:
  • In Sept 2022, Enterome's OncoMimics-based immunotherapy EO2401 was distinguished with the 'Best Clinical Research Award' at EANO Meeting 2022.
  • In April 2022, Vedanta Biosciences announced the publication in the journal Cell Host & Microbe of the results from a Phase 1a/1b study evaluating the safety, tolerability, and colonization dynamics of VE303 in healthy adults.

Human Microbiome Therapeutics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

22.3%

Largest Market

North American

Fastest Growing Market

Asia-Pacific

Human Microbiome Therapeutics Market Dynamics

The increasing focus on microbiome therapeutics development is driving the global human microbiome market. Human gut microbiomes are very important for healthy digestive systems. In the last decade, microbiome therapy has gained widespread importance due to the increasing rate of digestive problems, unhealthy lifestyles, and increasing consumption of junk food and fast food. According to Pan American Health Organization (PAHO), digestive disorders accounted for 375,170 deaths, 215,168 deaths in men, and 160,002 deaths in women in 2019. Hence, it will boost the global human microbiome market growth in the forecasted years.

Human Microbiome Therapeutics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 456.2 million

Market CAGR

22.3%

By Product Type

  • Prebiotics,
  • Probiotics,
  • Symbiotics,
  • Xenobiotics

By Application

  • Obesity,
  • Diabetes,
  • Autoimmune Disorders,
  • Cancer,
  • Gastrointestinal Disorders,
  • Central Nervous System Disorders,
  • Skin Care and
  • Oral Care,
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The human microbiome market size was valued at US$ 456.2 million in 2022

Enterome Bioscience, Seres Therapeutics, 4D pharma, Second Genome, Vedanta Biosciences, Ferring Pharmaceuticals, ViThera Pharmaceuticals, BiomX, DuPont, Kaleido, YSOPIA Bioscience, Metabiomics, Yakult Honsha, OptiBiotix

Global is the fastest-growing region for human microbiome market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Human Microbiome Therapeutics Market Introduction
2.1. Global Human Microbiome Therapeutics Market – Taxonomy
2.2. Global Human Microbiome Therapeutics Market – Definitions
2.2.1. Product Type
2.2.2. Application
3. Global Human Microbiome Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Human Microbiome Therapeutics Market Dynamic Factors - Impact Analysis
3.6. Global Human Microbiome Therapeutics Market – Competition Landscape
4. Global Human Microbiome Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Human Microbiome Therapeutics Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Prebiotics
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Probiotics
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Symbiotics
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Xenobiotics
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Human Microbiome Therapeutics Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029
6.1. Obesity
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Diabetes
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Autoimmune Disorders
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Cancer
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Gastrointestinal Disorders
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Central Nervous System Disorders
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Skin Care and Oral Care
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Others
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
7. Global Human Microbiome Therapeutics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Human Microbiome Therapeutics Market - Opportunity Analysis Index, By Product Type, Application, and Region,2023 - 2029
8. North America Human Microbiome Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. By Product Type Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Prebiotics
8.1.2. Probiotics
8.1.3. Symbiotics
8.1.4. Xenobiotics
8.2. Application Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Obesity
8.2.2. Diabetes
8.2.3. Autoimmune Disorders
8.2.4. Cancer
8.2.5. Gastrointestinal Disorders
8.2.6. Central Nervous System Disorders
8.2.7. Skin Care and Oral Care
8.2.8. Others
8.3. Country Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Human Microbiome Therapeutics Market - Opportunity Analysis Index, By Product Type, Application, and Country,2023 - 2029
8.5. North America Human Microbiome Therapeutics Market Dynamics – Trends
9. Europe Human Microbiome Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. By Product Type Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Prebiotics
9.1.2. Probiotics
9.1.3. Symbiotics
9.1.4. Xenobiotics
9.2. Application Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Obesity
9.2.2. Diabetes
9.2.3. Autoimmune Disorders
9.2.4. Cancer
9.2.5. Gastrointestinal Disorders
9.2.6. Central Nervous System Disorders
9.2.7. Skin Care and Oral Care
9.2.8. Others
9.3. Country Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Human Microbiome Therapeutics Market - Opportunity Analysis Index, By Product Type, Application, and Country,2023 - 2029
9.5. Europe Human Microbiome Therapeutics Market Dynamics – Trends
10. Asia-Pacific Human Microbiome Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. By Product Type Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prebiotics
10.1.2. Probiotics
10.1.3. Symbiotics
10.1.4. Xenobiotics
10.2. Application Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Obesity
10.2.2. Diabetes
10.2.3. Autoimmune Disorders
10.2.4. Cancer
10.2.5. Gastrointestinal Disorders
10.2.6. Central Nervous System Disorders
10.2.7. Skin Care and Oral Care
10.2.8. Others
10.3. Country Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Human Microbiome Therapeutics Market - Opportunity Analysis Index, By Product Type, Application, and Country,2023 - 2029
10.5. Asia-Pacific Human Microbiome Therapeutics Market Dynamics – Trends
11. Latin America Human Microbiome Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. By Product Type Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prebiotics
11.1.2. Probiotics
11.1.3. Symbiotics
11.1.4. Xenobiotics
11.2. Application Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Obesity
11.2.2. Diabetes
11.2.3. Autoimmune Disorders
11.2.4. Cancer
11.2.5. Gastrointestinal Disorders
11.2.6. Central Nervous System Disorders
11.2.7. Skin Care and Oral Care
11.2.8. Others
11.3. Country Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Human Microbiome Therapeutics Market - Opportunity Analysis Index, By Product Type, Application, and Country,2023 - 2029
11.5. Latin America Human Microbiome Therapeutics Market Dynamics – Trends
12. Middle East and Africa Human Microbiome Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. By Product Type Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prebiotics
12.1.2. Probiotics
12.1.3. Symbiotics
12.1.4. Xenobiotics
12.2. Application Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Obesity
12.2.2. Diabetes
12.2.3. Autoimmune Disorders
12.2.4. Cancer
12.2.5. Gastrointestinal Disorders
12.2.6. Central Nervous System Disorders
12.2.7. Skin Care and Oral Care
12.2.8. Others
12.3. Country Analysis 2018 - 2022 and Forecast, 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Human Microbiome Therapeutics Market - Opportunity Analysis Index, By Product Type, Application, and Country,2023 - 2029
12.5. MEA Human Microbiome Therapeutics Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Invivo Healthcare
13.2.2. MicroBiome Therapeutics LLC
13.2.3. Evolve Biosystems
13.2.4. Enterome SA
13.2.5. Seres Therapeutics
13.2.6. Finch Therapeutics
13.2.7. Second Genome Therapeutics
13.2.8. ViThera Pharmaceuticals Inc.
13.2.9. LNC Therapeutics SA
13.2.10. CoreBiome, Inc.
14. Research Methodology
15. Key Assumptions and Acronyms

Key Market Players

  • Enterome Bioscience
  • Seres Therapeutics
  • 4D pharma
  • Second Genome
  • Vedanta Biosciences
  • Ferring Pharmaceuticals
  • ViThera Pharmaceuticals
  • BiomX
  • DuPont
  • Kaleido
  • YSOPIA Bioscience
  • Metabiomics
  • Yakult Honsha
  • OptiBiotix

Related Industry Reports